BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16967707)

  • 1. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
    Naruszewicz M
    Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying patients with metabolic syndrome.
    Krentz AJ
    Practitioner; 2009; 253(1720):27-30. PubMed ID: 19715053
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute heart failure in a patient with metabolic syndrome and diabetes mellitus: clinical evidence for direct positive influence of antidiabetic therapy on left ventricular function.
    Ritzel A; Bell M; Jensen C; Sabin G
    Congest Heart Fail; 2009; 15(3):148-50. PubMed ID: 19522965
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D; Yanagisawa RT
    Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK: an emerging drug target for diabetes and the metabolic syndrome.
    Zhang BB; Zhou G; Li C
    Cell Metab; 2009 May; 9(5):407-16. PubMed ID: 19416711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orlistat reduces features of the metabolic syndrome: the XENDOS study.
    Holt R
    Diabetes Obes Metab; 2003 Sep; 5(5):356. PubMed ID: 14509281
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
    Krentz AJ; Clough G; Byrne CD
    J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic approach to choose anti-diabetic drugs].
    Hirukawa H; Kaku K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():626-31. PubMed ID: 21766672
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes 2: it is possible to prevent it].
    Rubin P
    Servir; 2004; 52(5):251-4. PubMed ID: 15600064
    [No Abstract]   [Full Text] [Related]  

  • 13. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 modulation as a novel approach to the treatment of diseases of aging.
    Blum CA; Ellis JL; Loh C; Ng PY; Perni RB; Stein RL
    J Med Chem; 2011 Jan; 54(2):417-32. PubMed ID: 21080630
    [No Abstract]   [Full Text] [Related]  

  • 15. Leapin' lizards: Amylin targets diabetes and obesity via incretins.
    Wolfson W
    Chem Biol; 2007 Mar; 14(3):235-6. PubMed ID: 17379135
    [No Abstract]   [Full Text] [Related]  

  • 16. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha-Glucosidase inhibitors].
    Horikawa Y; Takeda J
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():641-4. PubMed ID: 21766675
    [No Abstract]   [Full Text] [Related]  

  • 18. FGF21: a novel prospect for the treatment of metabolic diseases.
    Kharitonenkov A; Shanafelt AB
    Curr Opin Investig Drugs; 2009 Apr; 10(4):359-64. PubMed ID: 19337957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome following exposure to orlistat, ramipril, glimepiride in a woman with metabolic syndrome.
    Kalyoncu NI; Yaris F; Kadioglu M; Kesim M; Ulku C; Yaris E; Unsal M; Dikici M
    Saudi Med J; 2005 Mar; 26(3):497-9. PubMed ID: 15806235
    [No Abstract]   [Full Text] [Related]  

  • 20. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.